Tata Elxsi Share Price Target 2026, 2027, 2028, 2029, 2030
- Market Cap
- ₹23,312 Cr
- Book Value
- ₹489
- Stock P/E
- 33.1
- Dividend Yield
- 2.01%
- ROE
- 23.6%
- ROCE
- 30.0%
- PEG Ratio
- 2.41
- EV/EBITDA
- 20.5
Fundamentals from Screener.in, as of 5 Aug 2026. Live price via Yahoo Finance.
Technical snapshot
EOD ·Tata Elxsi Ltd closed at ₹3,716.80 on 3 November 2026, down 1.8% on the day, 7.3% above its 50-day average, 37.5% below its 52-week high, with volume at 0.27× its 20-session average.
- RSI 14
- 58.5
- vs 50-day SMA
- +7.3%
- vs 200-day SMA
- -8.2%
- From 52-week high
- -37.5%
- Relative volume
- 0.27×
- 20-day return
- +20.2%
End-of-day prices from exchange-published files (NSE/BSE bhavcopy), updated after market close. Descriptive statistics, not investment advice.
What the exchange files show
NSE EOD ·Tata Elxsi Ltd settled 24.6% of its traded volume as delivery on 3 November 2026, against a median of 36.4% across 109 sessions since 29 May 2026, below the 46.1% median for liquid NSE shares that day.
NSE's sec_list file assigns Tata Elxsi Ltd no daily price band — the marking carried by securities in the derivatives segment.
- Delivery, latest
- 24.6%
- Delivery, 109-session median
- 36.4%
- Delivery range
- 9.1–63.9%
- Daily price band
- None (F&O)
- Close x volume, latest
- ₹64 cr
- Series
- EQ
Disclosed bulk and block deals
| Date | Client | Side | Quantity | Price |
|---|---|---|---|---|
| 14 Oct 2026 | GRAVITON RESEARCH CAPITAL LLP | SELL | 4,93,713 | ₹3,656.53 |
| 14 Oct 2026 | GRAVITON RESEARCH CAPITAL LLP | BUY | 4,92,998 | ₹3,653.27 |
Every share bought was sold by someone, though a disclosure only names the client whose own trade crossed the threshold — the other side may not appear. All deals today →
Corporate actions
- 10 Jun 2026 — Dividend - Rs 75 Per Share
Prices, delivery and the price band come from NSE's published end-of-day files (sec_bhavdata_full and sec_list), covering 109 sessions from 29 May 2026. Surveillance status, disclosed deals and corporate actions come from separate NSE feeds on their own schedules and are not bounded by that window. Descriptive exchange data, not investment advice. What delivery percentage does and does not tell you →
Tata Elxsi share price today
Tata Elxsi (NSE: TATAELXSI) is Indian ER&D’s design house: engineering fused with industrial design across automotive (cockpits, ADAS, EV platforms), media & broadcast (OTT platforms, broadcast systems) and healthcare devices. Through the last upcycle it earned a 41% five-year average ROCE and a cult multiple; through the current one it has earned a lesson — growth has gone negative for three years as auto and media clients cut R&D, and the multiple compressed from three digits to 33.1×.
The debate is straightforward: this is a franchise waiting on the cycle. The brand, 22.5% operating margin and group relationships remain strengths; client demand is the missing ingredient.
Franchise intact, cycle absent
Elxsi’s differentiation — design-led engineering, where user experience and embedded software ship together — wins premium rates when clients are building new platforms, and stalls hardest when they pause. The auto pause (EV program deferrals globally) and media consolidation hit its two largest verticals simultaneously. Healthcare grows but is the smallest leg. The re-rating case is cyclical: R&D deferrals become R&D backlogs, and design-led shops recover with the sharpest operating leverage.
What matters next: auto R&D budget revival, healthcare-vertical scaling, deal-size trends versus the project-heavy past, and the 2% dividend yield, which adds some cash return during the slowdown.
The numbers
Financial snapshot — 5 August 2026
| Metric | Value |
|---|---|
| Market cap | ₹23,312 Cr |
| P/E (TTM) | 33.1 |
| EV/EBITDA | 20.5 |
| Operating margin | 22.5% |
| ROE / ROCE | 23.6% / 30.0% |
| Debt to equity | 0.05 |
| Sales CAGR (5y) | 15.5% |
| Profit CAGR (5y) | 13.8% |
| Promoter holding | 43.9% |
| EPS (TTM) | ₹113.0 |
Tata Elxsi share price target 2026 to 2030
EPS base ₹113.0 (TTM). Bear: the R&D winter drags on — 5% growth, multiple at 22×. Base: the cycle turns, design-led leverage returns — 11% growth at 29×. Bull: auto platforms and healthcare inflect together — 16% growth at 36×.
From ₹3,737, the base case is ≈ +48% over four and a half years plus the 2% yield; the bear is −15%. The range measures how much depends on an R&D recovery that has not yet appeared in reported growth.
What supports the case
- Design-led ER&D positioning no Indian peer fully replicates.
- 30% ROCE and 22.5% margins held through three down years — the franchise’s proof.
- Tata-group relationships can support domain access, though project wins still depend on capability and client budgets.
- A 2% dividend yield pays for cycle patience.
- The de-rating already happened — 33× versus the triple-digit past.
The risks: the growth stall could outlast patience, media-vertical decline may be structural, and the multiple still assumes the cycle turns rather than proving it.
What to weigh at the current price
The tension is whether auto and media R&D budgets recover before a prolonged growth stall turns the apparent cyclical pause into a structural concern.
FAQ
What is the Tata Elxsi share price target for 2030? The table above sets out bear, base and bull scenarios for each year to 2030. They are valuation sensitivities, not promised prices.
Why has Tata Elxsi’s growth turned negative? Global automakers deferred EV and ADAS programmes while media clients consolidated platforms, so its two biggest verticals paused R&D simultaneously. Some programmes may resume, while others can be reduced or cancelled; deal wins will show which outcome is occurring.
How is Elxsi different from LTTS or KPIT? Design-led breadth versus LTTS’s plant-engineering depth and KPIT’s automotive-software purity — Elxsi sells the user-facing layer plus embedded engineering as one offering.
When are Tata Elxsi’s next results? Check the results calendar and confirm the announced date in the company’s exchange filing.
This article is research and education, not personalised investment advice. We are not SEBI-registered advisers. Price targets are scenario arithmetic, not promises. Do your own research and consult a registered adviser before acting.